Amicus Therapeutics Inc (FOLD) — Cash Flow Reinvestment Rate
Amicus Therapeutics Inc (FOLD) has a Cash Flow Reinvestment Rate of 0.40x as of December 2025, reinvesting $6.49 Million (capex $299.00K plus investments $-6.20 Million) from operating cash flow of $16.25 Million. See Amicus Therapeutics Inc (FOLD) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Amicus Therapeutics Inc Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Amicus Therapeutics Inc across 2 annual periods. For the full cash flow conversion analysis, see FOLD cash flow metrics.
Annual Cash Flow Reinvestment Rate for Amicus Therapeutics Inc (2007–2025)
Year-by-year capital reinvestment analysis for Amicus Therapeutics Inc. See FOLD FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.40x | $46.43 Million | $33.15 Million | $3.30 Million | ▲ +3081.2% |
| 2007 | 0.04x | $669.00K | $15.19 Million | $669.00K | — |